Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7388)
All Articles published online
|
Publishing Process of This Article
|
Jun 28, 2014 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Guglielmi A, Ruzzenente A, Conci S, Valdegamberi A, Vitali M, Bertuzzo F, De Angelis M, Mantovani G, Iacono C. Hepatocellular carcinoma: Surgical perspectives beyond the barcelona clinic liver cancer recommendations. World J Gastroenterol 2014; 20(24): 7525-7533 [PMID: 24976693 DOI: 10.3748/wjg.v20.i24.7525] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i24/7525.htm |
| Number | Citing Articles |
| 1 |
Chong Wang, Lei Yang, Zikun Liang, Yaodong Liu, Shuku Liu. Long‐Term Survival and Prognostic Factors of Pulmonary Metastasectomy in Liver Cancer: A Systematic Review and Meta‐Analysis. World Journal of Surgery 2018; 42(7): 2153 doi: 10.1007/s00268-017-4431-7
|
| 2 |
Fan Yang, Le Shi, Tao Liang, Leilei Ji, Guangji Zhang, Yang Shen, Fangfang Zhu, Li Xu. Anti-tumor effect of evodiamine by inducing Akt-mediated apoptosis in hepatocellular carcinoma. Biochemical and Biophysical Research Communications 2017; 485(1): 54 doi: 10.1016/j.bbrc.2017.02.017
|
| 3 |
|
| 4 |
Lifang Ma, Qiuhui Pan, Fenyong Sun, Yongchun Yu, Jiayi Wang. Cluster of differentiation 166 (CD166) regulates cluster of differentiation (CD44) via NF-κB in liver cancer cell line Bel-7402. Biochemical and Biophysical Research Communications 2014; 451(2): 334 doi: 10.1016/j.bbrc.2014.07.128
|
| 5 |
Eduard Jonas, Marc Bernon, Barbara Robertson, Chris Kassianides, Elie Keli, Kwaku Offei Asare, Isaac Olusegun Alatise, Michael Okello, Nana Oumarou Blondel, Kenedy Ondede Mulehane, Zeki Abdurahman Abubeker, Alaaeldin Awad Nogoud, Pueya Rashid Nashidengo, Onesai Chihaka, Christian Tzeuton, Geoffrey Dusheiko, Mark Sonderup, C Wendy Spearman. Treatment of hepatocellular carcinoma in sub-Saharan Africa: challenges and solutions. The Lancet Gastroenterology & Hepatology 2022; 7(11): 1049 doi: 10.1016/S2468-1253(22)00042-5
|
| 6 |
Ying Ma, Ming Ma, Ling Ma, Fengbo Zhang, Yumei Liu, Xiumin Ma. Downregulation of miR‑552 in hepatocellular carcinoma inhibits cell migration and invasion, and promotes cell apoptosis via RUNX3. Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.8061
|
| 7 |
Davide Roccarina, Avik Majumdar, Douglas Thorburn, Brian R Davidson, Emmanuel Tsochatzis, Kurinchi Selvan Gurusamy. Management of people with intermediate-stage hepatocellular carcinoma. Cochrane Database of Systematic Reviews 2017; doi: 10.1002/14651858.CD011649.pub2
|
| 8 |
Chiuyen Phan, Ziyang Zheng, Jianwei Wang, Qiwen Wang, Xiurong Hu, Guping Tang, Hongzhen Bai. Enhanced antitumour effect for hepatocellular carcinoma in the advanced stage using a cyclodextrin-sorafenib-chaperoned inclusion complex. Biomaterials Science 2019; 7(11): 4758 doi: 10.1039/C9BM01190K
|
| 9 |
Saneya Pandrowala, Shraddha Patkar, Mahesh Goel, Darius Mirza, S. K. Mathur. Surgical resection for large hepatocellular carcinoma and those beyond BCLC: systematic review with proposed management algorithm. Langenbeck's Archives of Surgery 2023; 408(1) doi: 10.1007/s00423-023-02881-w
|
| 10 |
CHANGHE ZHANG, XIAOFEI CAO, YONGXIANG GEI, YONG WANG, GUIYUAN LIU, GUOCHANG CHENG, QINGHONG LIU. Silencing of survivin by YM155 induces apoptosis and growth arrest in hepatocellular carcinoma cells. Oncology Letters 2015; 10(3): 1627 doi: 10.3892/ol.2015.3451
|
| 11 |
Yao-Li Chen, Shih-Hsuan Chan, Ping-Yi Lin, Pei-Yi Chu. The expression of a tumor suppressor gene JDP2 and its prognostic value in hepatocellular carcinoma patients. Human Pathology 2017; 63: 212 doi: 10.1016/j.humpath.2017.03.003
|
| 12 |
Wang Yuhuang, Li Kang, Bai Chen, Feng Guodong, Zhang Xiuming, Shi Dan, Zhang Yu, Liu Nianlong. The application of magnetic resonance ultrasmall magnetic Fe3O4 nano bimodal contrast agent in rabbit orthotopic liver tumors. Precision Medical Sciences 2022; 11(3): 130 doi: 10.1002/prm2.12078
|
| 13 |
Tian Yang, Wan-Yee Lau, Han Zhang, Bin Huang, Jun-Hua Lu, Meng-Chao Wu. Grey zone in the Barcelona Clinic Liver Cancer Classification for hepatocellular carcinoma: Surgeons’ perspective. World Journal of Gastroenterology 2015; 21(27): 8256-8261 doi: 10.3748/wjg.v21.i27.8256
|
| 14 |
A Lei Feng, Jian Kang Zhu, Yupeng Yang, Ya Dong Wang, Feng Yue Liu, Min Zhu, Chong Zhong Liu. Repeated postoperative adjuvant TACE after curative hepatectomy improves outcomes of patients with HCC. Minimally Invasive Therapy & Allied Technologies 2021; 30(3): 163 doi: 10.1080/13645706.2019.1707689
|
| 15 |
Sonia T. Orcutt, Daniel A. Anaya. Liver Resection and Surgical Strategies for Management of Primary Liver Cancer. Cancer Control 2018; 25(1) doi: 10.1177/1073274817744621
|
| 16 |
Hai-Bing Lv, Qing-Yun Wu, Yu-Jiao Zhang, Sheng-Wei Quan, Ning Ma, Yu-Qing Dai, Yan Sun. Study on the expression and prognostic relationship of <i>MYL6B</i> in liver cancer based on bioinformatics. World Journal of Clinical Oncology 2024; 15(9): 1188-1197 doi: 10.5306/wjco.v15.i9.1188
|
| 17 |
Sandeep Arora, Carla Harmath, Roberta Catania, Ari Mandler, Kathryn J. Fowler, Amir A. Borhani. Hepatocellular carcinoma: metastatic pathways and extra-hepatic findings. Abdominal Radiology 2021; 46(8): 3698 doi: 10.1007/s00261-021-03151-3
|
| 18 |
Rodolfo Sacco, Michela Antonucci, Giampaolo Bresci, Ambra Corti, Luca Giacomelli, Valeria Mismas, Maurizio Rainieri, Antonio Romano, Roberto Eggenhoffner, Emanuele Tumino, Giuseppe Cabibbo. Curative therapies for hepatocellular carcinoma: an update and perspectives. Expert Review of Anticancer Therapy 2016; 16(2): 169 doi: 10.1586/14737140.2016.1123625
|
| 19 |
R. K. Tannus, S. R. Almeida-Carvalho, C. A. Loureiro-Matos, A. Miziara-Gonzalez, A. A. Salzedas-Netto, D. Szejnfeld, G. D'Ippolito, V. Pereira-Lanzoni, I. Souza-Silva, Ferruccio Bonino. Evaluation of survival of patients with hepatocellular carcinoma: A comparative analysis of prognostic systems. PLOS ONE 2018; 13(4): e0194922 doi: 10.1371/journal.pone.0194922
|
| 20 |
Jin‐Yu Sun, Tailang Yin, Xiao‐Yu Zhang, Xiao‐Jie Lu. Therapeutic advances for patients with intermediate hepatocellular carcinoma. Journal of Cellular Physiology 2019; 234(8): 12116 doi: 10.1002/jcp.28019
|
| 21 |
CHENG-ZUO XIAO, WEI WEI, ZHI-XING GUO, SHU-HONG LI, YONG-FA ZHANG, JIA-HONG WANG, MING SHI, RONG-PING GUO. A prognosis model for patients with hepatocellular carcinoma and portal vein tumor thrombus following hepatic resection. Oncology Letters 2015; 10(5): 2787 doi: 10.3892/ol.2015.3677
|
| 22 |
Jae Ho Sohn, Rafael Duran, Yan Zhao, Florian Fleckenstein, Julius Chapiro, Sonia Sahu, Rüdiger E. Schernthaner, Tianchen Qian, Howard Lee, Li Zhao, James Hamilton, Constantine Frangakis, MingDe Lin, Riad Salem, Jean-Francois Geschwind. Validation of the Hong Kong Liver Cancer Staging System in Determining Prognosis of the North American Patients Following Intra-arterial Therapy. Clinical Gastroenterology and Hepatology 2017; 15(5): 746 doi: 10.1016/j.cgh.2016.10.036
|
| 23 |
Yiqi Yu, Jingwen Ai, Wenhong Zhang. Current clinical evidence for nucleos(t)ide analogues in patients with HBV-related hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2017; 11(10): 925 doi: 10.1080/17474124.2017.1343665
|
| 24 |
Zhendong Gao, Gang Du, Yuguang Pang, Zhihao Fu, Chongzhong Liu, Yi Liu, Binghai Zhou, Du Kong, Binyao Shi, Zhengcheng Jiang, Bin Jin. Adjuvant transarterial chemoembolization after radical resection contributed to the outcomes of hepatocellular carcinoma patients with high-risk factors. Medicine 2017; 96(33): e7426 doi: 10.1097/MD.0000000000007426
|
| 25 |
Osama M. Elsanousi, Murtada A. Mohamed, Fatima H. Salim, Elsadig A. Adam, Shahinaz Bedri. Long-term outcome of novel combined surgical-injection treatment (COSIT) for large hepatocellular carcinoma: Stage 2A IDEAL prospective case series. Annals of Medicine and Surgery 2021; 72: 103098 doi: 10.1016/j.amsu.2021.103098
|
| 26 |
Yutao Yuan, Fangnian Yang, Yuanyuan Wang, Yusong Guo. Factors associated with liver cancer prognosis after hepatectomy. Medicine 2021; 100(42): e27378 doi: 10.1097/MD.0000000000027378
|
| 27 |
Jiang-feng Xu, Xi-yu Liu, Shuai Wang, Huai-xi Wen. Surgical treatment for hepatocellular carcinoma with portal vein tumor thrombus: a novel classification. World Journal of Surgical Oncology 2015; 13(1): 86 doi: 10.1186/s12957-015-0493-x
|
| 28 |
Abid Suddle, Helen Reeves, Richard Hubner, Aileen Marshall, Ian Rowe, Dina Tiniakos, Stefan Hubscher, Mark Callaway, Dinesh Sharma, Teik Choon See, Maria Hawkins, Suzanne Ford-Dunn, Sarah Selemani, Tim Meyer. British Society of Gastroenterology guidelines for the management of hepatocellular carcinoma in adults. Gut 2024; 73(8): 1235 doi: 10.1136/gutjnl-2023-331695
|
| 29 |
Mahmoud A. Dawoud, Rania E. Mohamed, Mohamed S. El Waraki, Ahmed M. Gabr. Single-session combined radiofrequency ablation and transarterial chemoembolization in the treatment of hepatocellular carcinoma. The Egyptian Journal of Radiology and Nuclear Medicine 2017; 48(4): 935 doi: 10.1016/j.ejrnm.2017.06.005
|
| 30 |
Kurinchi Selvan Gurusamy, Emmanuel Tsochatzis, Douglas Thorburn, Brian R Davidson, Kurinchi Selvan Gurusamy. Cochrane Database of Systematic Reviews. 2015; doi: 10.1002/14651858.CD011649
|
| 31 |
Eloy Ruiz, Teresa Rojas Rojas, Francisco Berrospi, Ivan Chávez, Carlos Luque, Luis Cano, Franco Doimi, Pascal Pineau, Eric Deharo, Stéphane Bertani. Hepatocellular carcinoma surgery outcomes in the developing world: A 20-year retrospective cohort study at the National Cancer Institute of Peru. Heliyon 2016; 2(1): e00052 doi: 10.1016/j.heliyon.2015.e00052
|
| 32 |
Maria Baimas-George, Christoph Tschuor, Michael Watson, Jesse Sulzer, Patrick Salibi, David Iannitti, John B. Martinie, Erin Baker, Pierre-Alain Clavien, Dionisios Vrochides. Current trends in vena cava reconstructive techniques with major liver resection: a systematic review. Langenbeck's Archives of Surgery 2021; 406(1): 25 doi: 10.1007/s00423-020-01989-7
|
| 33 |
Jianchu Wang, Zongjiang Luo, Tianwei Yao, Wenchuan Li, Jian Pu. LINC00707 promotes hepatocellular carcinoma progression through activating ERK/JNK/AKT pathway signaling pathway. Journal of Cellular Physiology 2019; 234(5): 6908 doi: 10.1002/jcp.27449
|
| 34 |
Chung-Lin Hung, Chia-Shen Yen, Hung-Wen Tsai, Yu-Chieh Su, Chia-Jui Yen. Upregulation of MicroRNA-19b predicts good prognosis in patients with hepatocellular carcinoma presenting with vascular invasion or multifocal disease. BMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1671-5
|
| 35 |
Mattia Garancini, Enrico Pinotti, Stefano Nespoli, Fabrizio Romano, Luca Gianotti, Vittorio Giardini. Hepatic resection beyond barcelona clinic liver cancer indication: When and how. World Journal of Hepatology 2016; 8(11): 513-519 doi: 10.4254/wjh.v8.i11.513
|
| 36 |
Jill Gwiasda, Aron Schulte, Alexander Kaltenborn, Wolf Ramackers, Moritz Kleine, Oliver Beetz, Jürgen Klempnauer, Nikos Emmanouilidis, Harald Schrem. Identification of the resection severity index as a significant independent prognostic factor for early mortality and observed survival >5 and >10 years after liver resection for hepatocellular carcinoma. Surgical Oncology 2017; 26(2): 178 doi: 10.1016/j.suronc.2017.03.004
|
| 37 |
Ru‑Ting Xie, Xian‑Ling Cong, Xiao‑Ming Zhong, Ping Luo, Hui‑Qiong Yang, Gai‑Xia Lu, Pei Luo, Zheng‑Yan Chang, Ran Sun, Ting‑Miao Wu, Zhong‑Wei Lv, Da Fu, Yu‑Shui Ma. MicroRNA-33a downregulation is associated with tumorigenesis and poor prognosis in patients with hepatocellular carcinoma. Oncology Letters 2018; doi: 10.3892/ol.2018.7892
|
| 38 |
Stefania Brozzetti, Simone Bini, Chiara D’Alterio, Chiara De Lucia, Leonardo Luca Chiarella, Katia Fazzi, Michele Di Martino. Liver Disease and Surgery [Working Title]. 2019; doi: 10.5772/intechopen.86638
|
| 39 |
Fangfang Liang, Fuchao Ma, Jincai Zhong. Prognostic factors of patients after liver cancer surgery. Medicine 2021; 100(30): e26694 doi: 10.1097/MD.0000000000026694
|
| 40 |
Guoyong Chen, Jiabin Zhang, Jianjun Sun, Sidong Wei, Jianbin Chen, Hui Ren, Shaotang Zhou. Revisiting Partial Hepatectomy of Large Hepatocellular Carcinoma in Older Patients. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-32798-0
|
| 41 |
Jan Erik Slotta, Otto Kollmar, Volker Ellenrieder, B Michael Ghadimi, Kia Homayounfar. Hepatocellular carcinoma: Surgeon's view on latest findings and future perspectives. World Journal of Hepatology 2015; 7(9): 1168-1183 doi: 10.4254/wjh.v7.i9.1168
|
| 42 |
Yi‐Chia Chan, Catherine S. Kabiling, Vinod G. Pillai, Gustavo Aguilar, Chih‐Chi Wang, Chao‐Long Chen. Survival Outcome Between Hepatic Resection and Transarterial Embolization for Hepatocellular Carcinoma More Than 10 cm: A Propensity Score Model. World Journal of Surgery 2015; 39(6): 1510 doi: 10.1007/s00268-015-2975-y
|
| 43 |
Shraddha Patkar, Amir Parray, Balu Mahendra, Sagar Kurunkar, Mahesh Goel. Performance of Hong Kong Liver Cancer staging system in patients of hepatocellular carcinoma treated with surgical resection: An Indian validation study. Journal of Surgical Oncology 2019; 120(7): 1119 doi: 10.1002/jso.25704
|
| 44 |
Kenji Wakayama, Toshiya Kamiyama, Hideki Yokoo, Tatsuya Orimo, Shingo Shimada, Takahiro Einama, Hirofumi Kamachi, Akinobu Taketomi. Huge hepatocellular carcinoma greater than 10 cm in diameter worsens prognosis by causing distant recurrence after curative resection. Journal of Surgical Oncology 2017; 115(3): 324 doi: 10.1002/jso.24501
|
| 45 |
SalehA Alqahtani, FaisalM Sanai, Ashwaq Alolayan, Faisal Abaalkhail, Hamad Alsuhaibani, Mazen Hassanain, Waleed Alhazzani, Abdullah Alsuhaibani, Abdullah Algarni, Alejandro Forner, RichardS Finn, WaleedK Al-hamoudi. Saudi Association for the Study of Liver diseases and Transplantation practice guidelines on the diagnosis and management of hepatocellular carcinoma. Saudi Journal of Gastroenterology 2020; 26(7): 1 doi: 10.4103/sjg.SJG_477_20
|
| 46 |
Pasquale Zizza, Chiara Cingolani, Simona Artuso, Erica Salvati, Angela Rizzo, Carmen D'Angelo, Manuela Porru, Bruno Pagano, Jussara Amato, Antonio Randazzo, Ettore Novellino, Antonella Stoppacciaro, Eric Gilson, Giorgio Stassi, Carlo Leonetti, Annamaria Biroccio. Intragenic G-quadruplex structure formed in the human CD133 and its biological and translational relevance. Nucleic Acids Research 2016; 44(4): 1579 doi: 10.1093/nar/gkv1122
|
| 47 |
Dan-Yun Ruan, Ze-Xiao Lin, Tian-Tian Wang, Hui Zhao, Dong-Hao Wu, Jie Chen, Min Dong, Qu Lin, Xiang-Yuan Wu, Yang Li. Nomogram for preoperative estimation of long-term survival of patients who underwent curative resection with hepatocellular carcinoma beyond Barcelona clinic liver cancer stage A1. Oncotarget 2016; 7(38): 61378 doi: 10.18632/oncotarget.11358
|